These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3196509)

  • 1. Easy production of sterile, pyrogen-free dialysate.
    Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K
    ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammation in hemodialysis: the role of contaminated dialysate.
    Lonnemann G
    Blood Purif; 2000; 18(3):214-23. PubMed ID: 10859424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis.
    Port FK; VanDeKerkhove KM; Kunkel SL; Kluger MJ
    Am J Kidney Dis; 1987 Aug; 10(2):118-22. PubMed ID: 3496789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a new hemodiafiltration (HDF) system.
    Rindi P; Pilone N; Riccò V; Cioni L
    ASAIO Trans; 1988; 34(3):765-8. PubMed ID: 3196595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies of dialysis-related endotoxemia and bacteremia.
    Bernick JJ; Port FK; Favero MS
    Nephron; 1981; 27(6):307-12. PubMed ID: 7266719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
    Geremia I; Bansal R; Stamatialis D
    Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
    ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
    Lonnemann G; Sereni L; Lemke HD; Tetta C
    Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of endotoxins in high-flux dialysis.
    Smollich BP; Falkenhagen D; Schneidewind J; Mitzner S; Klinkmann H
    Nephrol Dial Transplant; 1991; 6 Suppl 3():83-5. PubMed ID: 1775273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the JMS fully automated dialysis machine.
    Tsuchiya S; Moriishi M; Takahashi N; Watanabe H; Kawanishi H; Kim ST; Masaoka K
    ASAIO J; 2003; 49(5):547-53. PubMed ID: 14524562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrogen retention by the polyamide membranes.
    Lonnemann G; Mahiout A; Schindler R; Colton CK
    Contrib Nephrol; 1992; 96():47-63. PubMed ID: 1740050
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.
    Gordon SM; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Favero MS; Jarvis WR
    J Am Soc Nephrol; 1992 Mar; 2(9):1436-44. PubMed ID: 1627766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens.
    Lonnemann G
    Kidney Int Suppl; 1993 Jun; 41():S195-200. PubMed ID: 8320919
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-efficiency membranes and the dialysis solution].
    Agliata S; Airoldi G; Baroni A; Boschetti M; Schweiger K; Fortina F; Ragazzoni E; Cavagnino A
    Minerva Urol Nefrol; 1990; 42(1):39-42. PubMed ID: 2389221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin.
    Pegues DA; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Gordon SM; Favero MS; Jarvis WR
    J Am Soc Nephrol; 1992 Oct; 3(4):1002-7. PubMed ID: 1450362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.